Key result
Accelerated chest pain protocol yields no 30-day major cardiovascular events despite only ~47% completing timely follow-up.
Why the study?
The ability of low-risk chest pain patients identified by the HEART Score in the ED to receive adequate outpatient follow-up was uncertain.
Implementation of a HEART score-based accelerated diagnostic protocol for low-risk chest pain patients revealed inadequate rates of outpatient follow-up and cardiac testing, prompting further quality improvement efforts.
Answers are grounded in this paper and cite their sources.
Zero 30-day MACE supports protocol safety yet poor follow-up raises caution; leaves open whether adherence improves outcomes in observational cohorts.
CONTEXT: The authors in the Emergency Department (ED) at McLaren Oakland utilized the Plan-Do-Study-Act (PDSA) model to implement, evaluate and incrementally modify a Chest Pain Accelerated Diagnostic Protocol (CPADP) using the History, EKG, Age, Risk Factors, Troponin (HEART) Score at their institution. The objective of this study was to evaluate the ability of patients who presented to the ED with chest pain and fell into the low risk category based on their HEART Score to receive adequate outpatient follow-up for their chest pain. METHODS: Modifying protocols implemented at other institutions, in 2016 the authors developed CP-ADP utilizing the HEART Score to risk-stratify patients presenting to the ED with chest pain as low, moderate or high risk for major adverse cardiac events (MACE). Patients identified as low risk were offered the options of hospital observation or being discharged home with outpatient follow-up within seven days. Patients who were risk-stratified into the medium or high risk for MACE were admitted into the in-patient setting for cardiac evaluation. Once implemented, the protocol was evaluated to measure patient follow-up within thirty days. RESULTS: During a five-month period, 50 patients presenting to the ED with chest pain were risk-stratified as low risk for adverse cardiac events and opted for discharge from the ED to follow-up in the outpatient setting. A total of 18 patients were lost to follow up, and two patients subsequently returned to the ED for further evaluation of their chest pain and were admitted to the inpatient setting. These two patients were not included in the analysis. Thirty patients were successfully contacted by telephone 30 days postdischarge. Of those 30 patients contacted, none experienced any MACE events. However, only 14 (47%) low risk patients followed up with a primary care provider or cardiologist and only four (13%) received provocative cardiac testing (i.e., stress testing). CONCLUSIONS: Only 47% of patients discharged from the ED received outpatient follow-up and only 13% received cardiac testing. As a result of the study, the multi-disciplinary Chest Pain Committee has progressed to the Act 'A' step of the PDSA cycle to modify the authors' protocol to ensure more clinically appropriate outpatient follow-up for patients discharged under the CP-ADP.
No takes yet. Share an insight, caveat, or question.
Breckner et al. (2017) studied Chest pain (n=50). Chest Pain Accelerated Diagnostic Protocol (CP-ADP) was evaluated on Outpatient follow-up with a primary care provider or cardiologist within 7 days. Among low-risk chest pain patients discharged from the emergency department under an accelerated diagnostic protocol, none experienced major adverse cardiac events at 30 days, though only 47% completed outpatient follow-up within seven days.
Synapse has enriched 10 related papers. Consider them for comparative context: